70%的本报告因处理延误在上述日期提交吡虫啉

Imidacloprid Technical: 95% Min.Formulation: Imidacloprid 70% WP, 25% WP, 10% WP, 200G/L SL, 100G/L SLChemical name: 1-((6-Chloro-3-pyridinyl) methyl)-N-nitro-imidazolidinimineCAS REG No.: 138261-41-3Molecular formula: C9H10ClN5O2Molecular mass: 255.7Technical standard:imidacloprid 95% Min. TCAPPEARANCEWHITE POWDERA.I. CONTENT, %95 MIN.LOSS ON DRYING, %1.0 MAX.SODA, %0.2 MAX.Formulation standard:imidacloprid 70% WPAPPREANCEWHITE POWDERA.I. CONTENT, %70.0 MIN.Suspensibility ,%80.0 MINWet sieve test(44um) s98.0 MINIMIDACLOPRID 70% WSAPPREANCEPINK POWDERA.I. CONTENT, %70.0 MIN.Suspensibility ,%80.0 MINPH VALUE5.0-7.0WATER CONTENT, %2.0 MAX.imidacloprid 25% WPAPPREANCEWHITE POWDERA.I. CONTENT, %25.0 MIN.Suspensibility ,%80.0 MINWet sieve test(44um) s98.0 MINimidacloprid 10% WPAPPREANCEWHITE POWDERA.I. CONTENT, %10.0 MIN.Suspensibility ,%80.0 MINWet sieve test(44um) s98.0 MINimidacloprid 200G/L SLAPPREANCEYELLOW transparent LIQUIDA.I. CONTENT, G/L200.0 MIN.WATER CONTENT,%0.5 MAXDILUTION STABILITY(200TIMES)QUALIFIEDLOW-TEMPERATUREQUALIFIEDHIGH-TEMPERATUREQUALIFIEDimidacloprid 100G/L SLAPPREANCEYELLOW transparent LIQUIDA.I. CONTENT, G/L100.0 MIN.WATER CONTENT,%0.5 MAXDILUTION STABILITY(200TIMES)QUALIFIEDLOW-TEMPERATUREQUALIFIEDHIGH-TEMPERATUREQUALIFIEDPacking:Powder: 25Kg drum or customizedLiquid: 200Ltr plastic drum or customizedPhysicochemical PropertiesDensity1.54M.P.: 144°CVapour pressure, Pa at 20°C: negligibleSolubility (20): in water 0.061 g/100MlOctanol/water partition coefficient as log POW: 0.57Spillage disposal:Sweep spilled substance into containers. Carefully collect remainder, then remove to safe place. Personal protection: P2 filter respirator for harmful particles. Do not let this chemical enter the environment.Storage: Separated from food and feedstuffs.Toxicological:Imidacloprid given orally as a single dose was moderately toxic to rats (LD50, 380650 mg/kg bw) and mice (LD50, 130170 mg/kg bw). Behavioural and respiratory signs, disturbances of motility, narrowed palpebral fissures, transient trembling and spasms were seen in rats and mice treated orally at doses > 200 mg/kg bw and > 71 mg/kg bw, respectively. The clinical signs were reversed within 6 days. Imidacloprid given intraperitoneally showed moderate to low acute toxicity in rats, the signs being similar to those after oral administration. Very little toxicity was seen after acute dermal application. The LC50 for a single exposure to an aerosol could not be determined exactly, as rats tolerated inhalation for 4 h of the maximum concentration of dust that could be produced technically (0.069 mg/l of air) without signs or deaths.